abstract |
The present invention relates to camelid heavy chain antibody variable domains directed to phosphorylated tau protein and conjugates thereof. The invention also relates to the use of these domains or conjugates for the treatment or diagnosis of diseases mediated by neurofibrillary tangles, neuropil threads or dystrophic neurites (eg tauopathy). [Selection figure] None |